Natera’s Signatera Blood Test May Help Breast Cancer Patients Avoid Surgery
Natera’s Signatera test, a circulating tumor DNA (ctDNA) assay, may allow select breast cancer patients—particularly those over 70—to safely avoid surgery. By detecting molecular residual disease (MRD), the test identifies ... Read More